CUBE Tech Fair welcomes spectacular speakers

CUBE10 - 12 May 2017, Berlin, Germany.
CUBE Tech Fair welcomes Brigitte Zypries, Germany's Federal Minister for Economic Affairs and Energy. CUBE is inspired by her work at the Ministry of Economics, in which she places a strong emphasis on advancing the Industry 4.0. She supports startups as well as SMBs (small & medium-sized businesses), where she promotes various financial instruments and network opportunities offered by the BMWi.

More Speakers

Samantha Payne

Founder of Open Bionics
Co-Founder of Open Bionics; an award-winning startup developing low-cost bionic hands that look and feel good, for amputees or those born without a hand. Now part of the Disney Accelerator, powered by Techstars. Samantha, recently named as one of the top 25 women in robotics you need to know about by Robohub and Marie Claire's Top Women In Tech. The startup has won multiple other awards for innovation, including being named one of the top 50 robotics businesses in the world alongside Google and Amazon.

Pablos Holman

Futurist, inventor, and notorious hacker.
He has helped create the world's smallest PC; 3D printers at Makerbot; & spaceships with Jeff Bezos. Currently, Pablos is working for Nathan Myhrvold & Bill Gates at the Intellectual Ventures Laboratory inventing solutions to the world's biggest problems.

Jonathan Yoni Ofir

CEO of LEAF
LEAF is the plug-n-plant™ system that automatically grows medical plants and food from the comfort of your home. Yoni founded LEAF in 2015 after he decided to build a growing system for his own needs and encountered overwhelming consumer demand. In September 2015 LEAF was the first ever cannabis startup to participate in Techrunch Disrupt Battlefield. LEAF was named Product Hunt 2016 Hardware Product of the Year and was featured on VICELAND's Weediquette.

Joseph Brunner

CEO of Relayr
Josef Brunner serves as relayr’s Chief Executive Officer. Josef has been instrumental in launching multiple IT and Cyber Security companies, like JouleX (2009) and Bastille Networks (2004). Before starting relayr, he completed his tenure with Cisco Systems, which began after the 2013 Cisco acquisition of JouleX, where he was Co-Founder and Chief Architect. Josef is also an active venture capitalist through his venture capital firm AFT Ventures.

World Pharma News readers can benefit from an exclusive discount - get 30% off the ticket price using our unique promo code worldpharmanewsCUBE17 when you register online here.

Hint: The faster you buy your ticket, the cheaper it is.

About CUBE
CUBE is a Berlin-based global innovation ecosystem that aims to promote, create and foster partnerships between industry players and startups in life sciences & digital health, machinery & manufacturing as well as infrastructure & connectivity. Being part of the CUBE ecosystem allows all participants to collaborate on innovative products and ideas in response to concrete industry needs.

The annual CUBE Tech Fair, our flagship event, will take place for the first time in May 2017. For further information, please visit http://tech-fair.cube-global.com.

Most Popular Now

FDA approves Roche's OCREVUS™ (ocrelizumab) for re…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) approved OCREVUS™ (ocrelizumab) as the first and only medicine for both ...

Read more

First collaborative definition of patient centrici…

AstraZeneca announced that BMJ Innovations has published the first collaborative definition of patient centricity for the pharmaceutical industry. The definition was co-d...

Read more

High doses of vitamin C to improve cancer treatmen…

Clinical trials found that it is safe to regularly infuse brain and lung cancer patients with 800 - 1000 times the daily recommended amount of vitamin C as a potential st...

Read more

Deep learning algorithm could boost drug developme…

Artificially intelligent algorithms can learn to identify amazingly subtle information, enabling them to distinguish between people in photos or to screen medical images ...

Read more

Bristol-Myers Squibb enters into separate agreemen…

Bristol-Myers Squibb Company (NYSE:BMY) today announced that it has entered into two separate agreements to license BMS-986168, an anti-eTau compound in development for ...

Read more

Tagrisso (osimertinib) receives US FDA full approv…

AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted full approval for Tagrisso (osimertinib) 80mg once-daily tablets, for the treatment...

Read more

A one-two punch hits pancreatic cancer where it hu…

Australian scientists have uncovered a promising new approach to treating pancreatic cancer, by targeting the tissue around the tumour to make it 'softer' and more respon...

Read more

FDA allows marketing of first direct-to-consumer t…

The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are ...

Read more

Novartis to strengthen R&D pipeline by in-lice…

Novartis has exercised an option to in-license ECF843 for ophthalmic indications worldwide (outside Europe). The closing of the deal is subject to customary closing condi...

Read more

New drug delivery system shows promise for fightin…

A new cancer-drug delivery system shows the ability to exploit the oxygen-poor areas of solid tumors that make the growths resistant to standard chemotherapy and radiatio...

Read more

Towards a safe and scalable cell therapy for type …

More than 36 million people globally are affected by type 1 diabetes (T1D), a lifelong disorder where insulin producing cells are attacked and destroyed by the immune sys...

Read more

XELJANZ® (tofacitinib citrate) receives marketing …

Pfizer Inc. (NYSE:PFE) announced today that the European Commission (EC) has approved XELJANZ® (tofacitinib citrate) 5 mg twice daily (BID) oral tablets in combination wi...

Read more

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]